For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...

Edgewise Therapeutics , Inc., a biotechnology company specializing in pharmaceutical preparations, announced the promotion of ...

Kawan's updated price target for Haleon's American Depositary Receipts (ADRs) considers the recent movements in the GBP/USD ...

Pfizer is approaching a whole new era of growth after launching a record number of new products and putting a focus on its ...

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.

The carrier expects an adjusted loss of between 40 cents and 20 cents per share, steeper than the 4 cents per share loss estimated by Wall Street.

The Schwab U.S. Dividend Equity ETF offers automatic diversification, income, and growth. Read what makes SCHD a solid ...

On Monday the company closed a US$996 million ($1.6bn) loan, including US$968m in principal and US$28m of capitalised interest, a US$268m mark up from a conditional loan announced for its Rhyolite ...

SCHD ETF effectively combines dividend income and dividend growth, while offering investors a reduced Expense Ratio. Click ...